Are there risks associated with combining filazonatant with CYP1A2 inhibitors?

Fezolinetant, as a new type of non-hormonal drug, is mainly metabolized by the liver in the body. One of its metabolic pathways involves the cytochrome P450 enzyme system, especially the CYP1A2 enzyme. CYP1A2 inhibitors are widely present in clinical practice, such as fluvoxamine, ciprofloxacin and certain antipsychotic drugs, which can significantly inhibit the activity of this enzyme. When fezonatant is combined with these strong inhibitors of CYP1A2, its metabolic clearance rate may be reduced, leading to accumulation of the drug in the body, thereby increasing the risk of adverse reactions, especially in patients with hepatic insufficiency or older patients.

According to FDA review data and clinical pharmacokinetic models, when used concurrently with CYP1A2 inhibitors, the blood concentration of fizonatant may increase significantly, thereby increasing the possibility of side effects, such as headache, nausea, elevated liver enzymes, etc., and may even increase the existing burden on the liver. Given the dose-dependent effects and potential for hepatotoxicity of fezonatant, extreme caution should be exercised when coadministering CYP1A2 inhibitors. Regulatory agencies recommend that when co-administration cannot be avoided, adjustment of the dose of fezonastat should be considered and liver function indicators should be closely monitored.

When prescribing fezonatant, clinicians should fully evaluate whether other drugs used by the patient are CYP1A2 inhibitors. Especially among people who regularly use psychotropic drugs or antibacterial drugs, the possibility of drug interactions should be carefully evaluated. In addition, if patients need to take CYP1A2 inhibitors for a long time, they may need to weigh the risks and benefits of continuing to use fezonatant, or even choose alternative treatment options to ensure drug safety. Therefore, the risks of combined use of fezonatantwithCYP1A2 inhibitors cannot be ignored and should be fully supervised and regularly evaluated by professional doctors.

Reference materials:https://www.veozah.com/